Alfa Scientific Designs, Inc. appears in FDA device records as the applicant for K262299, the Instant-View® hCG Combo II Cassette Test, a traditional 510(k) with a substantially equivalent decision dated September 22, 2026. The submission was received July 7, 2026, and carries product code JHI, classified as a visual pregnancy hCG test for prescription use under regulation 862.1155 in the Clinical Chemistry advisory committee. The FDA filing address is 13200 Gregg St., Poway, CA 92064, with Michael Chien listed as applicant contact. That address is a filing address, not a verified headquarters. [1][2]

The documented 510(k) record

The supplied collection contains one linked record, a 510(k) with a single SESE decision, and the record sample likewise holds one entry, K262299. The decision description reads Substantially Equivalent, the clearance type is Traditional, the third-party flag is N, and the statement field indicates a Summary. The device name in the FDA record is Instant-View® hCG Combo II Cassette Test, and the openFDA device name is Visual, Pregnancy Hcg, Prescription Use, device class 2. [1][2]

A separate CLIA database entry lists K262299 against the analyte category Urine hCG by visual color comparison tests, specialty Endocrinology, with a WAIVED status dated September 23, 2026. That entry is a distinct FDA database row from the 510(k) decision record and should be read as a separate regulatory listing rather than a restatement of the clearance. [3]

Company-published product scope

Alfa Scientific Designs, Inc. states on its own site that it develops and manufactures rapid immunoassay point-of-care tests and offers contract product development, technology transfer, OEM services, custom assembly, and packaging with private labeling. The same publisher states the company was established in 1996 and that products are developed and manufactured in the USA. Its technology center page describes a portfolio of rapid immunoassays for cardiac and cancer markers, drugs of abuse, fertility hormones and infectious diseases. [4]

The company profile page, published by Alfa, describes a California-licensed, cGMP compliant and ISO 13485 registered manufacturer of in-vitro diagnostic devices, founded in 1996, with more than 50 products developed since then and 28 patents granted. These are company assertions about itself, not independently verified certifications or counts. The profile also states that Alfa specializes in rapid immunoassays. [5]

Fertility test line and use settings

Alfa's fertility test page describes Instant-view® hCG rapid pregnancy tests using lateral flow technology with urine or urine/serum specimens in dip strip, stick, single cassette and midstream formats, listing a sensitivity of 25 mIU/ml and stating the tests are developed and manufactured in the USA and cleared for professional, CLIA and OTC markets. The same page lists an Instant-View® Pregnancy Urine/Serum Cassette Test under a product code. [8]

A company FAQ states that only the Instant-View® Midstream Test is cleared for over-the-counter sale and home use, while the Instant-View® hCG and hCG Combo (Urine/Serum) Tests are not cleared for over-the-counter sale or home use and are classified as CLIA-waived for use by appropriately trained personnel in CLIA-waived facilities. That FAQ does not name the Combo II Cassette Test specifically, so its use setting is not established by that text. [6]

Reading the record correctly

The single linked filing is an as-of snapshot of linked FDA records, not a measure of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. The applicant identity on K262299 is Alfa Scientific Designs, Inc.; no parent, brand owner or corporate affiliate is verified in the public documents, and the company's own pages do not name one. [1][4]